The company aims to invest in biomedical research and development projects in collaboration with universities and leading biomaterial researchers, to own intellectual property rights related to these research and development activities, to license intellectual property rights from biomedical research companies, and to commercially license intellectual property rights on global target markets. The company may acquire, hold, encumber and sell real estate. The company may establish branches and subsidiaries in Switzerland and abroad and participate in other companies. The company may carry out all commercial, financial and other activities that are connected with the purpose of the company.